Verrica Pharmaceuticals Inc.
VRCA
$0.6231
-$0.0507-7.52%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -39.53% | -33.38% | -72.77% | -42.09% | -18.37% |
| Total Receivables | -25.56% | -98.26% | -97.94% | 5,800.58% | 13,460.71% |
| Inventory | -1.60% | 141.00% | 826.16% | -- | -- |
| Prepaid Expenses | -24.62% | -9.23% | -16.50% | 69.13% | -24.12% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -35.68% | -33.99% | -69.27% | -16.66% | -2.73% |
|
|
|||||
| Total Current Assets | -35.68% | -33.99% | -69.27% | -16.66% | -2.73% |
| Net Property, Plant & Equipment | -48.02% | -28.66% | -14.19% | -15.02% | -13.42% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -16.81% | -16.81% | 2.28% | 3.90% | 22.49% |
| Total Assets | -36.39% | -33.66% | -66.11% | -16.38% | -3.40% |
|
|
|||||
| Total Accounts Payable | -42.90% | -23.05% | -49.82% | -44.09% | 339.48% |
| Total Accrued Expenses | -52.45% | -62.16% | 8.16% | 50.55% | 348.25% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1,233.56% | 1,843.57% | 234.58% | 240.13% | 234.44% |
| Total Finance Division Other Current Liabilities | 25.58% | 83.02% | 266.78% | 13,796.77% | 3,880.36% |
| Total Other Current Liabilities | 25.58% | 83.02% | 266.78% | 13,796.77% | 3,880.36% |
| Total Current Liabilities | 51.80% | 70.42% | 84.86% | 249.87% | 632.69% |
|
|
|||||
| Total Current Liabilities | 51.80% | 70.42% | 84.86% | 249.87% | 632.69% |
| Long-Term Debt | -35.10% | -27.73% | 2.13% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -55.34% | -30.22% | 147.38% | 134.39% | 124.87% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -6.24% | 3.49% | 22.12% | 860.30% | 1,608.38% |
|
|
|||||
| Common Stock & APIC | 18.19% | 18.77% | 3.48% | 7.71% | 7.41% |
| Retained Earnings | -26.31% | -33.23% | -41.29% | -48.02% | -47.48% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -1,331.83% | -149.89% | -180.49% | -124.01% | -97.67% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1,331.83% | -149.89% | -180.49% | -124.01% | -97.67% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1,331.83% | -149.89% | -180.49% | -124.01% | -97.67% |
|
|
|||||